Company Filing History:
Years Active: 2013
Title: Aitor Beraza Pérez: Innovator in Stem Cell Therapy
Introduction
Aitor Beraza Pérez is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of medical science, particularly in the treatment of graft-versus-host disease (GVHD). His innovative approach utilizes adipose-derived mesenchymal stem cells, showcasing the potential of stem cell therapy in modern medicine.
Latest Patents
Aitor Beraza Pérez holds a patent for a method of treating graft-versus-host disease using adipose-derived mesenchymal stem cells. This invention relates to the use of a specific type of adipose tissue-derived mesenchymal stem cells (AD-MSCs), which possess immunosuppressive properties. The patent outlines the manufacture of a pharmaceutical composition aimed at preventing and treating GVHD, a condition that can arise after allogeneic hematopoietic stem cell transplantation.
Career Highlights
Throughout his career, Aitor has worked with prominent organizations, including the Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas and Tigenix, S.A. His work in these institutions has allowed him to advance his research and contribute to the development of innovative therapies.
Collaborations
Aitor has collaborated with esteemed colleagues in his field, including Manuel Angel González De La Peña and Dirk Büscher. These partnerships have fostered a collaborative environment that enhances research and innovation in stem cell therapy.
Conclusion
Aitor Beraza Pérez is a pioneering inventor whose work in stem cell therapy has the potential to transform the treatment of graft-versus-host disease. His contributions to medical science highlight the importance of innovation in improving patient outcomes.